John Montana - Galapagos Managing Argenta
| GLPG Stock | EUR 24.98 0.50 1.96% |
Insider
John Montana is Managing Argenta of Galapagos NV
| Phone | 32 1 534 29 00 |
| Web | https://www.glpg.com |
Galapagos Management Efficiency
The company has return on total asset (ROA) of (0.0119) % which means that it has lost $0.0119 on every $100 spent on assets. This is way below average. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities.Galapagos NV has accumulated 27.91 M in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Galapagos NV has a current ratio of 8.71, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Galapagos until it has trouble settling it off, either with new capital or with free cash flow. So, Galapagos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Galapagos NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Galapagos to invest in growth at high rates of return. When we think about Galapagos' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Arjen MSc | Argen X | 38 | |
| EMBA MBA | Argen X | 50 | |
| Dirk Zimmermann | Biocartis Group NV | N/A | |
| Pr Ir | Argen X | 63 | |
| MBA MD | Pharming Group NV | 63 | |
| Erwin Sablon | Biocartis Group NV | 58 | |
| Susanne Embleton | Pharming Group NV | N/A | |
| Herman Verrelst | Biocartis Group NV | 49 | |
| Andria Wilk | Argen X | 49 | |
| Anurag Relan | Pharming Group NV | 51 | |
| Mireille MSc | Pharming Group NV | 55 | |
| Peter Agnefjaell | Koninklijke Ahold Delhaize | 48 | |
| Frank Zanten | Koninklijke Ahold Delhaize | 53 | |
| Chris Sluys | Barco NV | 63 | |
| Beth DelGiacco | Argen X | N/A | |
| Katie Doyle | Koninklijke Ahold Delhaize | 52 | |
| JeanMarc Roelandt | Biocartis Group NV | 58 | |
| Geert Carrein | Barco NV | 65 | |
| Iain Urquhart | Barco NV | 50 | |
| Elvira Bos | Koninklijke Ahold Delhaize | N/A | |
| Stephen Toor | Pharming Group NV | 52 | |
Management Performance
| Return On Equity | 0.0021 | |||
| Return On Asset | -0.0119 |
Galapagos NV Leadership Team
Elected by the shareholders, the Galapagos' board of directors comprises two types of representatives: Galapagos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galapagos. The board's role is to monitor Galapagos' management team and ensure that shareholders' interests are well served. Galapagos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galapagos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elizabeth Goodwin, VP Corporate Communications & Investor Relations | ||
| Andre Hoekema, Senior Vice President - Corporate Development | ||
| John Montana, Managing Argenta | ||
| Michele MBA, Chief Board | ||
| Walid AbiSaab, Member of the Executive Committee, Chief Medical Officer | ||
| Marieke Vermeersch, Head Communication | ||
| Chantal Tasset, Head Devel | ||
| Sofie Gijsel, Head Relations | ||
| MBA MBA, COO Pres |
Galapagos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Galapagos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0021 | |||
| Return On Asset | -0.0119 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | (2 B) | |||
| Shares Outstanding | 65.84 M | |||
| Shares Owned By Insiders | 26.24 % | |||
| Shares Owned By Institutions | 32.13 % | |||
| Price To Earning | (146.88) X | |||
| Price To Book | 0.87 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Galapagos Stock Analysis
When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.